Practical Guide to Full-Process Agency Procedures for Test Kit Export to EU 2026

EU Market Access Background and Challenges

In 2026,the global in-vitro diagnostic (IVD) market landscape has undergone profound changes.As an important destination for China’s test kit export,the EU’s regulatory environment has become more stringent after the full implementation of IVDR regulation.For many domestic test kit manufacturers,this is both an opportunity and a huge challenge.Many business owners like Mr.Xiao,despite owning high-quality product technology,often feel overwhelmed when facing the EU’s complex access thresholds,cumbersome customs declaration documents and changing logistics requirements.Issues such as cargo detention at ports,document rejection,and overly long tax refund cycles not only increase operating costs,but also seriously damage enterprises’ international reputation.Against this background,cooperating with a professional foreign trade agency has become the key to solving export difficulties.

Core Value of Agency Services by Zhongshen

In response to the increasingly stringent access threshold of the EU market,the export agency service provided by Zhongshen is not just simple logistics arrangement,but a complete set of compliance solutions.We have been deeply engaged in the industry for more than 20 years,and fully understand that test kit export in 2026 is no longer simple cargo transportation,but a comprehensive trade-off among regulatory compliance,logistics timeliness and capital security.The core of our service is to convert complex international trade rules into standardized operation procedures.Leveraging our profound experience in customs declaration and inspection,international transportation,foreign exchange management and export tax refund,we provide door-to-door solutions from factory to overseas customers for clients like Mr.Xiao,ensuring that every transaction maximizes efficiency on the premise of compliance.

Document Review and Compliance Access

The primary challenge for test kit export to the EU lies in document compliance.In 2026,EU Customs has significantly strengthened the inspection of EUDAMED data,and any minor defect on documents may lead to the detention of the entire shipment.

Policy Barriers and Risk Points

The EU requires test kits to meet the classification requirements of IVDR regulation,and different risk levels correspond to different review paths.Common risk points include:

• Product Performance Evaluation Report (PPER) is not updated or does not meet the latest standards.
• EU Authorized Representative (EC-REP) information on documents does not match the actual filing information.
• Lack of Unique Device Identification (UDI) code,or the UDI-DI on the label does not match the database information.
• The instruction manual does not include the official language version of any EU member state.

Countermeasures by Zhongshen

Zhongshen has established a special medical device document review team.After taking over Mr.Xiao’s project,we first determine the product risk level,confirm whether it belongs to Class A,Class B or higher risk level.Then we assist the enterprise to prepare technical documents that meet IVDR requirements,ensuring that CE certificates,declaration of conformity,and documents signed by EU authorized representative are complete and logically consistent.Especially for UDI labels,we will guide enterprises to print correctly and declare accurately on the customs declaration,avoiding inspection caused by mismatch between label information and system data.In addition,we also strictly review commercial invoices and packing lists to ensure all declaration elements fully correspond to the HS Code.

International Transportation and Customs Clearance Logistics

Logistics of test kits has obvious particularity,involving multiple dimensions including biosafety,temperature-controlled storage and dangerous goods transportation.The inspection rate of medical goods by EU customs is generally higher than that of ordinary goods,and inspection standards are becoming increasingly stringent.

Logistics Difficulties and Regulatory Requirements

EU ports have very strict entry inspection for biological products,focusing on cold chain control and biosafety.

• Risk of temperature control failure: Some reagents require 2-8℃ cold chain transportation throughout the journey,and temperature out of range will lead to product inactivation.
• Dangerous goods declaration: Test kits containing flammable solvents or specific biological factors need to provide MSDS report and correct labeling,complying with packaging specifications such as UN3373.
• Inspection timeliness: EU Customs has a high sampling rate for medical goods,and inspection may involve opening packages.Improper packaging can easily cause cargo damage.

Countermeasures by Zhongshen

In response to the above logistics difficulties,Zhongshen has integrated high-quality international logistics resources with medical qualification.We customize transportation plans according to product characteristics.For example,for temperature-controlled reagents,we use TAPA-certified cold chain logistics service providers throughout the journey,and place real-time temperature recorders in packaging to ensure full-process temperature data traceability.In customs declaration,we adopt the "advance declaration" mode,leveraging our good credit at Shanghai Port to prioritize document review and reduce cargo detention time in supervised warehouses.For urgent orders like Mr.Xiao’s,we can also coordinate with the destination port customs clearance agent to provide pre-clearance service,greatly shortening the overall logistics cycle and ensuring goods enter the market for sale as soon as possible.

Foreign Exchange Settlement and Export Tax Refund

The speed of capital withdrawal and tax refund arrival directly affects the cash flow health of foreign trade enterprises,especially for medical enterprises with huge R&D investment,capital efficiency is extremely important.

Capital Circulation Pain Points

Under the traditional self-operated export mode,enterprises often face the following pain points:

• Long foreign exchange collection cycle,exchange rate fluctuation leads to profit shrinkage,and lack of professional risk hedging tools.
• Tax refund declaration materials are complicated,once invoice information does not match customs declaration information,the tax refund process may be suspended indefinitely.
• Lack of professional financial staff to handle complex foreign-related tax declaration,which easily leads to tax risks due to operational errors.

Countermeasures by Zhongshen

Zhongshen provides one-stop foreign exchange and tax refund services.We have opened multi-currency settlement channels,support flexible settlement and foreign exchange purchase solutions,helping customers avoid exchange rate risks.In terms of tax refund,we have established a standardized tax refund declaration process.From input certification of purchase invoices to obtaining export customs declarations,and then to entering and declaring tax refund data,we implement full-process closed-loop management.With 20 years of deep industry experience,we maintain efficient communication with tax authorities and customs,and can quickly handle abnormal situations such as tax refund correspondence investigation.Generally,for export via Zhongshen agency,the tax refund cycle is significantly shorter than that of enterprise self-operated operation,which effectively improves capital turnover,allowing business owners like Mr.Xiao to devote more energy to product R&D and market expansion.

Comparative Analysis of Agency Service Efficiency

To more intuitively show the advantages of agency services,we compare the differences in key links between enterprise self-operated export and export delegated to Zhongshen.

Customized Export Solution Selection

Test kit export is a systematic project,involving multiple dimensions including product attributes,destination country policies,logistics conditions and capital settlement.After experiencing a setback in self-operated export,Mr.Xiao chose to entrust all business to Zhongshen,which not only solved compliance problems,but also released the productivity of his internal team.Whether you are an experienced enterprise deeply engaged in the medical industry for many years,or a new manufacturer that just received overseas orders,Zhongshen can customize the most suitable foreign trade agency plan according to your specific product characteristics and target market requirements.We recommend you to communicate in depth with our expert team before shipment,avoid potential risks through professional pre-assessment,and let your test kit products move unimpeded in the international market.